Business Stat Slide

8/2/2019 Business Stat Slide

1/30

Group#02


2/30

Topic:Statistical Comparison betweenSquare Pharmaceuticals Ltd. &Beximco Pharmaceuticals Ltd.

By PresenterMedia.com
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


3/30

Group Members

1

2

3

4

Mahfuz ArefinID: 17-060

Shama DasID: 17-015

Chamak DewanID: 17-095

5 Nowshin MahbubID: 17-097

Fahmida Akter SuchanaID: 17-0089
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


4/30

Agenda

1

23

4

Financial Analysis:BeximcoPharmaceuticals Ltd.

Financial Analysis: Square Pharmaceutical Ltd

Interpretation of the financial Data

5Comparison between the companies

Company Overview
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


5/30

Beximco Pharmaceuticals Ltd.
http://www.presentermedia.com/mspp.html


6/30

Beximco Pharmaceuticals Ltd

Beximco Pharma aspires to become a nationally admiredand globally reputed generic pharmaceuticalcompany, committed to enhancing human health and life.

Beximco Pharmaceuticals Ltd., is a leading manufacturer andexporter of active pharmaceutical ingredients (APIs) in Bangladesh.

It is the only Bangladeshi company with an AIM listing onthe London Stock Exchange.

The company employs more than 2,500 people

The company was incorporated in 1976 and listed on DSEin 1985.

CmpOevew
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


7/30

Highlights of the financial data

(In billion) 2006 2007 2008 2009 2010 Total

Net profit after tax .47 .35 .55 .62 1.05 3.04

Gross profit 1.73 1.63 2 2.3 3.17 10.83Cost of goods sold 1.97 1.97 2 2.57 3.32 11.83

Operating

expense

.98 .97 1 1.3 1.54 5.79

Other Income .06 .02 .000686 .2 .46 .74

http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


8/30

0

0.2

0.4

0.6

0.8

1

1.2

2006 2007 2008 2009 2010

Net Profit After Tax
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


9/30

Mean of the Variables

Variables Mean(In Billion Tk)

Net profit

after tax

4.96

Gross profit 2.79

Cost of goods

sold

2.05

Operating

expense

1.02

Other Income 5.65


10/30

Variance & Standard Deviation

The population Variance of net profit after tax is 0.0569.

And the Standard Deviation is 0.24.

Variance & Standard Deviation are based on the deviations fromthe mean. Here, we use the square value of the deviations.
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


11/30

Coefficient of Correlation

Profit after tax

Cost of goods

sold

Operating

expense

Other income

Profit after

tax

1 .663 .646 .642

Cost of goods

sold

1 .995 .940

Operating

expense

1 .913

Other income 1
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


12/30

profit after

tax

cost of

goods sold

operating

expense

other

income

operting expense 0.646 0.995 1 0.913

profit after tax 1 0.663 0.646 0.642

cost of goods sold 0.663 1 0.995 0.94

other income 0.642 0.94 0.913 1

0

0.2

0.40.6

0.8

1

1.2

AxisTitle

Chart Title
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


13/30

Here Magnitude of R is .465And Magnitude of Adjusted R Square -1.140

As R square is greater than adjusted R square, new variables canhave no effect on the prediction. So, there is no need of addingnew variables.


14/30

Square Pharmaceuticals Ltd.


15/30

Square Pharmaceuticals Ltd.

The Companys mission is to produce and providequality & innovative healthcare relief forpeople, maintain stringently ethical standard in businessoperation also ensuring benefit to theshareholders, stakeholders and the society at large.

Established as a partnership company in 1958.

Incorporate as a private Limited company in 1964.

Converted into a Public Limited Company in 1991.

The Company was listed in Stock Exchange in 1995.

CmpOevew
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


16/30

Highlights of the financial Data

(In billion Tk.) 2006 2007 2008 2009 2010 Total

Net profit after tax 1.17 1.13 1.38 1.89 2.09 7.66

Gross profit 2.56 3.23 3.4 4.15 4.9 18.24

Cost of goods sold 3.53 4.27 4.86 5.67 6.56 24.89

Operating expense .98 1.41 1.69 1.78 2.21 8.07

Other Income .17 .22 .6 .67 .59 2.25

Square Pharmaceuticals Limited
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


17/30

0

0.5

1

1.5

2

2.5

2006 2007 2008 2009 2010

Net Profit After Tax
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


18/30

Mean of the Variables

Variables Mean

Net profit

after tax1.57

Gross profit4.98

Cost of goods

sold4.98

Operating

expense1.62

Other

Income

4.49


19/30

Coefficient of Correlation

Profit after tax

Cost of goods

sold

Operating

expense Other income

Profit after

tax

1 .971 .902 .758

Cost of goodssold

1 .979 .824

Operating

expense

1 .826

Oter income 1
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


20/30

Profit after

tax

cost of

goods sold

operating

expense

other

income

profit after tax 1 0.971 0.902 0.758

cost of goods sold 0.971 1 0.979 0.824

operating expense 0.902 0.979 1 0.826

other income 0.758 0.824 0.826 1

0

0.2

0.40.6

0.8

1

1.2

Axis

Title

Chart Title
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


21/30

Here R square is .999

And Adjusted R square is .996

Since R square, is greater than adjusted RSquare, new variables can not have any effect on theprediction.


22/30

Comparison


23/30

Mean

Variables Beximco Pharma Square Pharma

Profit after tax 4.961.57

Gross profit 2.794.98

Cost of goods sold 2.054.98

Operating expense 1.02 1.62

Other income 5.65 4.49
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


24/30

Comparison between Net Profit after Tax

0

0.5

1

1.5

2

2.5

3

3.5

2006 2007 2008 2009 2010

Square

Beximco
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


25/30

Variance & Standard Deviation

The population Variance of net profit after tax is 0.151

And the Standard Deviation is 0.39

Variance & Standard Deviation are based on the deviations fromthe mean. Here, we use the square value of the deviations.


26/30

Comparison between corrrelation

BeximcoAmong the variables operating expense influence Net profit aftertax more. The correlation between operating expense & netprofit after tax is .646.

Square

Among the variables cost of goods sold influence net profit aftertax more. The correlation between cost of goods sold & netprofit after tax is .971.
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


27/30

Return on Equity

The ratio of return on equity of Beximco is 5.55%.

The ROE of Square is 17.89%.


28/30

Quartile

Q1 Q2 Q3

Net profit after

tax

.35 .55 .62

Gross profit 1.63 2 2.3

Cost of goods

sold

1.97 2 2.57

Operating

expense

.97 1 1.3

Other Income .02 .06 .2



29/30

Quartile

Q1 Q2 Q3

Net profit after

tax

1.17 1.38 1.89

Gross profit 3.23 3.4 4.15

Cost of goods

sold

4.27 4.86 5.67

Operating

expense

1.41 1.69 1.78

Other Income .22 .59 .6

Square Pharmaceuticals Limited
http://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.htmlhttp://www.presentermedia.com/mspp.html


30/30

Documents

Business Stat Slide